Biomarin Pharmaceutical Inc at Robert W Baird Global Healthcare Conference (Virtual) Transcript
All right. Great, and good morning. And thanks to everyone for joining us at the Baird 2020 Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here at Baird, and it's my pleasure to introduce the team from BioMarin, including J.J. Bienaimé, Chairman and CEO. We also have Brian Mueller, CFO; and Hank Fuchs, President of Worldwide Research and Development.
So just a quick reminder, the format for today is a fireside chat. So if you have a question, please feel free to submit one through the webcast portal, which is anonymous, and I'll be sure to ask a question on your behalf. But before we jump into the Q&A here, I'll just turn it over to J.J. to make some introductory comments. J.J.?
©,-&
Yes. Thank you, Mike. We appreciate the opportunity to speak with you today. It has been a very active few weeks for us,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
